The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Evidence of Benefit

Added text about the Swedish Malmo Preventive Medicine cardiovascular risk study, which specifically tested whether total PSA velocity improves the accuracy of total PSA level to predict long-term risk of prostate cancer (cited Ulmert et al. as reference 60).

Added text to state that tPSAv did not aid long-term prediction of cancer in early middle-aged men.

Back to Top

< Previous Section  |  Next Section >